Who We Are

Passage Bio has a focused mission to provide life-transforming therapies for patients with CNS disorders that replace their suffering with boundless possibility

Our company is a genetics medicine company based in Philadelphia, PA, a city with a rich history of scientific discovery and medical advancement. As a leading developer of cutting-edge therapeutics for disorders of the central nervous system (CNS), we are proud to be a part of this dynamic research community. We are also excited about our new laboratory at the Princeton West Innovation Campus in Hopewell, New Jersey, which will help us evolve the standard for biotech innovation and development.

who we are image


What Passage Bio brings to families affected by CNS disorder

A bold vision to fulfill the promise of gene therapy by delivering medicines that provide a cure for previously incurable diseases

A differentiated approach to gene therapy development through our collaboration with Penn’s GTP and Orphan Disease Center

A deep pipeline of optimized gene therapies for CNS disorders, including three lead programs focused on the following devastating diseases:

what passage bio brings


See what’s on the horizon

See what’s on the horizon

Learn about the therapies we’re working on.

Review Our Pipeline

Take a deeper dive

Take a deeper dive

Learn more about the science behind our work.

Review Our Science